McCarthy Sean A. - Insider Non-Derivative Transactions at CytomX Therapeutics, Inc. (CTMX) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Nov 6, 2025, McCarthy Sean A.'s relationship to CytomX Therapeutics, Inc. (CTMX) is Director,Officer (CEO), and currently has 1,089,684 shares of Common Stock, and 987,891 shares of Class A Common Stock.

The charts below show the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other CTMX insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

McCarthy Sean A. - Insider Non-Derivative Transactions of CTMX Common Stock

McCarthy Sean A. - Insider Non-Derivative Transactions of CTMX Class A Common Stock

McCarthy Sean A. - Insider Non-Derivative Transactions at CTMX

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Nov 7, 2025	Sell -- (Class A Common Stock)	101793	4.54	987891
Jun 17, 2025	Sell -- (Common Stock)	55511	2.69	1089684
Jun 14, 2025	M -- (Common Stock)	150000	0	1145195
Mar 19, 2025	Sell -- (Common Stock)	37656	0.6	995195
Feb 5, 2025	Acquisition -- (Common Stock)	180000	0	837851
Feb 5, 2025	Acquisition -- (Common Stock)	195000	0	1032851
Aug 21, 2024	Sell -- (Common Stock)	13898	1.23	657851
Aug 21, 2024	M -- (Common Stock)	37500	0	671749
Mar 27, 2024	M -- (Common Stock)	109768	1.57	634249
Mar 20, 2024	Sell -- (Common Stock)	20223	2.09	524481
Jan 19, 2024	Acquisition -- (Common Stock)	90000	0	544704
Dec 21, 2023	Sell -- (Common Stock)	13551	1.38	454704
Dec 18, 2023	M -- (Common Stock)	37500	0	468255
Sep 23, 2023	Sell -- (Common Stock)	14601	1.3	430755
Sep 21, 2023	Acquisition -- (Common Stock)	40000	0	445356
May 20, 2023	M -- (Common Stock)	16535	1.57	405356
Mar 17, 2023	Sell -- (Common Stock)	7121	1.88	388821
Feb 3, 2023	Acquisition -- (Common Stock)	105000	0	395942